Association of Soluble Immune Checkpoint Molecules PD1 and 4‐1BB With CTLA‐4Ig Treatment Response in Early Rheumatoid Arthritis

Association of Soluble Immune Checkpoint Molecules PD1 and 4‐1BB With CTLA‐4Ig Treatment Response in Early Rheumatoid Arthritis

Objective To investigate whether soluble immune checkpoint molecules in blood are associated with the treatment response to disease‐modifying antirheumatic drugs in early rheumatoid arthritis (eRA). Methods This study included 328 Swedish treatment‐naïve patients with eRA from the Nordic Rheumatic D...

Full description

Saved in:
Bibliographic Details
Main Authors: Tilia Selldén, Kristina Lend, Jon Lampa, Merete Lund Hetland, Mikkel Østergaard, Tillmann Uhlig, Dan Nordström, Kim Hørslev‐Petersen, Björn Gudbjörnsson, Gerdur Gröndal, Inger Gjertsson, Ronald vanVollenhoven, Cristina Maglio, Kerstin Andersson, Anna‐Karin Hultgård Ekwall, Anna‐Carin Lundell, Anna Rudin
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:ACR Open Rheumatology
Online Access:https://doi.org/10.1002/acr2.70069
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/acr2.70069

Similar Items